{
  "pmid": "30698924",
  "uid": "30698924",
  "title": "Regression of mucosal melanoma following intralesional talimogene laherparepvec (T-VEC) injection in combination with immunotherapy.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Drescher",
      "fore_name": "Christina",
      "initials": "C",
      "name": "Christina Drescher",
      "affiliations": [
        "Department of Dermatology, University Medical Center, Regensburg, Germany."
      ]
    },
    {
      "last_name": "Drexler",
      "fore_name": "Konstantin",
      "initials": "K",
      "name": "Konstantin Drexler",
      "affiliations": [
        "Department of Dermatology, University Medical Center, Regensburg, Germany."
      ]
    },
    {
      "last_name": "Hilber",
      "fore_name": "Hermann",
      "initials": "H",
      "name": "Hermann Hilber",
      "affiliations": [
        "Department of Ear, Nose and Throat Medicine, University Medical Center, Regensburg, Germany."
      ]
    },
    {
      "last_name": "Schmidt",
      "fore_name": "Barbara",
      "initials": "B",
      "name": "Barbara Schmidt",
      "affiliations": [
        "Institute of Clinical Microbiology and Hygiene, University Medical Center, Regensburg, Germany."
      ]
    },
    {
      "last_name": "Haferkamp",
      "fore_name": "Sebastian",
      "initials": "S",
      "name": "Sebastian Haferkamp",
      "affiliations": [
        "Department of Dermatology, University Medical Center, Regensburg, Germany."
      ]
    }
  ],
  "journal": {
    "title": "Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG",
    "iso_abbreviation": "J Dtsch Dermatol Ges",
    "issn": "1610-0387",
    "issn_type": "Electronic",
    "volume": "17",
    "issue": "3",
    "pub_year": "2019",
    "pub_month": "Mar"
  },
  "start_page": "321",
  "end_page": "323",
  "pages": "321-323",
  "language": "eng",
  "publication_types": [
    "Case Reports",
    "Letter"
  ],
  "keywords": [
    "Antineoplastic Agents, Immunological",
    "Biological Products",
    "Combined Modality Therapy",
    "Female",
    "Herpesvirus 1, Human",
    "Humans",
    "Immunotherapy",
    "Injections, Intralesional",
    "Maxillary Sinus Neoplasms",
    "Melanoma",
    "Middle Aged",
    "Nasal Mucosa"
  ],
  "article_ids": {
    "pubmed": "30698924",
    "doi": "10.1111/ddg.13763"
  },
  "doi": "10.1111/ddg.13763",
  "dates": {
    "completed": "2020-02-24",
    "revised": "2020-02-24"
  },
  "chemicals": [
    "Antineoplastic Agents, Immunological",
    "Biological Products",
    "talimogene laherparepvec"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:56:12.435274",
    "pmid": "30698924"
  }
}